Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Harvard Apparatus Regenerative Technology (HRGN) reported Return on Capital Employed [ROCE] of -1168.12% for Q1 2026, down 898.32 percentage points from -269.80% a year earlier and down 526.35 percentage points from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Harvard Apparatus Regenerative Technology posted Return on Capital Employed [ROCE] of -341.40%, down 33.22 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +75.27 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -308.18% in FY2024 (+275.97 pp), -584.15% in FY2023 (+214.95 pp) and -799.09% in FY2022.
  • The Q1 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2014.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last four quarters, with an average year-over-year change of -145.74 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2021 (a gain of 575.94 percentage points); the low point was Q1 2026 (a drop of 898.32 percentage points).
  • Per Business Quant data, the three quarters before Q1 2026 came in at -641.76% (Q4 2025), -449.13% (Q3 2025) and -435.40% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Harvard Apparatus Regenerative Technology 38.50 Mn 35.01 Mn 23,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,168.12%
Dec 31, 2025 -641.76%
Sep 30, 2025 -449.13%
Jun 30, 2025 -435.40%
Mar 31, 2025 -269.80%
Dec 31, 2024 -200.39%
Sep 30, 2024 -225.62%
Jun 30, 2024 -324.65%
Mar 31, 2024 -630.75%
Dec 31, 2023 -403.14%
Sep 30, 2023 -232.26%
Jun 30, 2023 -262.36%
Mar 31, 2023 -334.72%
Dec 31, 2022 -369.11%
Sep 30, 2022 -355.47%
Jun 30, 2022 -404.99%
Sep 30, 2021 -287.15%
Jun 30, 2021 -494.97%
Mar 31, 2021 -494.30%
Dec 31, 2020 -297.24%
API Access

Harvard Apparatus Regenerative Technology Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HRGN&period=max&api_key=YOUR_API_KEY